Page last updated: 2024-09-03

mozavaptan and pirenzepine

mozavaptan has been researched along with pirenzepine in 2 studies

Compound Research Comparison

Studies (mozavaptan)	Trials (mozavaptan)	Recent Studies (post-2010) (mozavaptan)	Studies (pirenzepine)	Trials (pirenzepine)	Recent Studies (post-2010) (pirenzepine)
165	8	24	3,812	587	140

Protein Interaction Comparison

Protein	Taxonomy	pirenzepine (IC50)
Muscarinic acetylcholine receptor M2	Homo sapiens (human)	0.6891
Muscarinic acetylcholine receptor M4	Homo sapiens (human)	0.5856
Muscarinic acetylcholine receptor M1	Rattus norvegicus (Norway rat)	0.6134
Muscarinic acetylcholine receptor M3	Rattus norvegicus (Norway rat)	0.6222
Muscarinic acetylcholine receptor M4	Rattus norvegicus (Norway rat)	0.6227
Muscarinic acetylcholine receptor M5	Rattus norvegicus (Norway rat)	0.6227
Muscarinic acetylcholine receptor M5	Homo sapiens (human)	0.3406
Muscarinic acetylcholine receptor M2	Rattus norvegicus (Norway rat)	0.6281
Muscarinic acetylcholine receptor M1	Homo sapiens (human)	0.0291
Muscarinic acetylcholine receptor M1	Mus musculus (house mouse)	0.75
Muscarinic acetylcholine receptor M3	Homo sapiens (human)	0.9556
Muscarinic acetylcholine receptor M4	Mus musculus (house mouse)	0.75
Muscarinic acetylcholine receptor M5	Mus musculus (house mouse)	0.75
Muscarinic acetylcholine receptor M3	Mus musculus (house mouse)	0.75
Muscarinic acetylcholine receptor M2	Mus musculus (house mouse)	0.51

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abe, K; Egawa, T; Fujii, M; Fujiwara, M; Inada, K; Iwasaki, K; Matsumoto, Y; Mishima, K; Tsukikawa, H	1
Abe, K; Egashira, N; Fujiwara, M; Inada, K; Iwasaki, K; Matsumoto, Y; Mishima, K; Miura, I; Tsukikawa, H	1

Other Studies

2 other study(ies) available for mozavaptan and pirenzepine

Article	Year
Ameliorative effect of vasopressin-(4-9) through vasopressin V(1A) receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze. European journal of pharmacology, 2001, Sep-07, Volume: 427, Issue:1 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetylcholine; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium Channel Blockers; Dose-Response Relationship, Drug; Hemicholinium 3; Hippocampus; Hormone Antagonists; Injections, Intraventricular; Male; Maze Learning; Memory; Memory Disorders; Neurotransmitter Uptake Inhibitors; Nicardipine; Peptide Fragments; Pirenzepine; Rats; Rats, Wistar; Receptors, Vasopressin; Scopolamine	2001
Ameliorative effect of NC-1900, a new AVP4-9 analog, through vasopressin V1A receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze. Neuropharmacology, 2003, Volume: 44, Issue:4 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium-Calmodulin-Dependent Protein Kinases; Cholinergic Antagonists; Maze Learning; Memory; Microdialysis; Nicardipine; Nootropic Agents; Oligopeptides; Pirenzepine; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Receptors, Vasopressin; Scopolamine	2003

Article

Year

Ameliorative effect of vasopressin-(4-9) through vasopressin V(1A) receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze.

European journal of pharmacology, 2001, Sep-07, Volume: 427, Issue:1

Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetylcholine; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium Channel Blockers; Dose-Response Relationship, Drug; Hemicholinium 3; Hippocampus; Hormone Antagonists; Injections, Intraventricular; Male; Maze Learning; Memory; Memory Disorders; Neurotransmitter Uptake Inhibitors; Nicardipine; Peptide Fragments; Pirenzepine; Rats; Rats, Wistar; Receptors, Vasopressin; Scopolamine

2001

Ameliorative effect of NC-1900, a new AVP4-9 analog, through vasopressin V1A receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze.

Neuropharmacology, 2003, Volume: 44, Issue:4

Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium-Calmodulin-Dependent Protein Kinases; Cholinergic Antagonists; Maze Learning; Memory; Microdialysis; Nicardipine; Nootropic Agents; Oligopeptides; Pirenzepine; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Receptors, Vasopressin; Scopolamine

2003